RECRUITING

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Talk to us

Conditions

Atopic DermatitisAlopecia AreataHidradenitis SuppurativaVitiligoPsoriasisChronic Spontaneous UrticariaIMISCRegistryObservationalImmune-mediated Inflammatory Skin Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Official Title

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

Quick Facts

Study Start:2018-12-21
Study Completion:2050-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03661866

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 1. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
  2. * 2. Participant has plans for future visits at the site for continued management of IMISC.
  1. * 1. Inability to provide written informed consent/assent.
  2. * 2. Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).

Contacts and Locations

Study Contact

Laura Dalfonso
CONTACT
9842340268
ldalfonso@targetrwe.com
Ashley Magee
CONTACT
8282793641
amagee@targetrwe.com

Principal Investigator

Laura Dalfonso
STUDY_DIRECTOR
Target RWE

Study Locations (Sites)

Clear Dermatology & Aesthetics Center/Investigative MD
Scottsdale, Arizona, 85255
United States
Johnson Dermatology
Fort Smith, Arkansas, 72916
United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
United States
Arkansas Dermatology
Little Rock, Arkansas, 72223
United States
First OC Dermatology
Fountain Valley, California, 92708
United States
Center for Dermatology Cosmetic and Laser Surgery
Fremont, California, 94538
United States
University of California
Irvine, California, 92697
United States
University of California - San Diego/Rady Children's Hospital
San Diego, California, 92123
United States
George Washington University
Washington, District of Columbia, 20037
United States
Feinstein Dermatology and Cosmetic Surgery
Hollywood, Florida, 33021
United States
Academic Alliance in Dermatology
Tampa, Florida, 33614
United States
Integrated Dermatology of West Palm Beach
West Palm Beach, Florida, 33406
United States
Lurie Children's Hospital/Northwestern University
Chicago, Illinois, 60611
United States
Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group
Indianapolis, Indiana, 46520
United States
The University of Kansas Medical Center
Kansas City, Kansas, 66160
United States
Family Allergy and Asthma Research Institute
Louisville, Kentucky, 40215
United States
DermAssociates, LCC
Rockville, Maryland, 20850
United States
Integrated Dermatology of Massachusetts
Quincy, Massachusetts, 02169
United States
University of Massachusetts Medical School
Worcester, Massachusetts, 01605
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States
Mayo Clinic
Rochester, Minnesota, 55905
United States
Carl Thornblade, MD, PLLC
Missoula, Montana, 59808
United States
South Lincoln Dermatology Clinic
Lincoln, Nebraska, 68502
United States
Advanced Dermatology of the Midlands
Omaha, Nebraska, 68144
United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756
United States
Windsor Dermatology
East Windsor, New Jersey, 08520
United States
Linda Susan Marcus
Wyckoff, New Jersey, 07481
United States
Montefiore Medical Center
Bronx, New York, 10467
United States
Centurion Dermatology
Brooklyn, New York, 11219
United States
The University of Buffalo
Buffalo, New York, 14203
United States
Empire Dermatology
East Syracuse, New York, 13057
United States
Forest Hills Dermatology Group
Forest Hills, New York, 11375
United States
Greenwich Village Dermatology
New York, New York, 10012
United States
Ichan School of Medicine
New York, New York, 10029
United States
Advanced Allergy & Asthma, PLLC
Rockville Centre, New York, 11570
United States
Allergy Partners of Western North Carolina
Asheville, North Carolina, 28801
United States
UNC Dermatology
Chapel Hill, North Carolina, 27516
United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
United States
Ohio State University
Columbus, Ohio, 43215
United States
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma, 73120
United States
Oregon Health and Science University
Portland, Oregon, 97239
United States
Allergy and Clinical Immunology
Pittsburgh, Pennsylvania, 15241
United States
The Medical University of South Carolina
Charleston, South Carolina, 29425
United States
El Paso Dermatology Center
El Paso, Texas, 79902
United States
North Texas Center for Clinical Research
Frisco, Texas, 75034
United States
Asthma and Allergy Center
Lewisville, Texas, 75067
United States
Center for Clinical Studies
Webster, Texas, 77598
United States
Allergy Associates of Utah
Murray, Utah, 84107
United States
University of Utah MidValley Dermatology
Murray, Utah, 84107
United States
Virginia Commonwealth University
Richmond, Virginia, 23219
United States
North Sound Dermatology
Mill Creek, Washington, 98012
United States
Spokane Dermatology Clinic
Spokane, Washington, 99202
United States
Dermatology Center for Skin Health
Morgantown, West Virginia, 26542
United States
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Target PharmaSolutions, Inc.

  • Laura Dalfonso, STUDY_DIRECTOR, Target RWE

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-21
Study Completion Date2050-12

Study Record Updates

Study Start Date2018-12-21
Study Completion Date2050-12

Terms related to this study

Keywords Provided by Researchers

  • Atopic Dermatitis
  • IMISC
  • Registry
  • Observational
  • Immune-mediated Inflammatory Skin Conditions

Additional Relevant MeSH Terms

  • Atopic Dermatitis
  • Alopecia Areata
  • Hidradenitis Suppurativa
  • Vitiligo
  • Psoriasis
  • Chronic Spontaneous Urticaria